Hainan Medical College Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02998242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Second Affiliated Hospital of Hainan Medical University | The Second Affiliated Hospital of Hainan Medical University, Hai Kou, China

Active Ingredients

Drugs in Phase 4 Trials (2)

ciprofol (1 trial)

remimazolam (Byfavo) (1 trial)

Drugs in Phase 1 Trials (2)

cd19-tricar-t (1 trial)

gpa-trimar-t (1 trial)

Drugs in Other Trials (1)

lapatinib (tykerb) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5